AstraZeneca boss sets out to woo investors
698
Sir Tom McKillop, the chief executive of AstraZeneca, will this week launch a charm offensive to reassure investors that the pharmaceutical group&#39;s prospects remain strong
109496
The used-car specialist delivers a growth spiel to Wall Street.
192321
Johnson Matthey led the gainers in London on Thursday amid reports that the platinum specialist could be a target for a US chemical group.
377721
Faced with the threat of generic competition, the company focuses its efforts on a new drug.
10738
A partnership deal has investors in the small specialty pharma excited.
211620
The drug maker's paperwork also is part of the actions required to issue shares in connection its proposed offer Polish pharmaceutical company known as Polfa Kutno.
93384
A veteran analyst provides some salient advice on getting the next big stock.
519169
LONDON (CBS.MW) -- Pharmaceutical giant AstraZeneca shares rose as it said earnings and sales both increased for the third quarter.
565203
Hedge fund manager Edward Lampert likes to buy undervalued companies and pursues what sounds like a simple plan that has earned him millions and a spot as one of America&#39;s top investors.
17097
The generic drug maker&#39;s deal to buy King Pharmaceuticals was supposed to mark its arrival in the brand-name drug business. Instead, it put the spotlight on a new CEO&#39;s strategy that billionaire investor Carl Icahn doesn&#39;t like.
752647
One of the pioneers of offshoring tries to cash in.
356288
By Rosie Murray-West, City Correspondent (Filed: 14/09/2004). Astrazeneca shares plummeted yesterday as investors and analysts digested the pharmaceutical giant&#39;s announcement over potential blockbuster drug Exanta.
461404
Trex hopes to gain market share and deck the competition.
619642
The activist investor looks to squeeze some more value out of the retailer's shares.
81672
The pharmaceutical giant is selling its pain relievers and other consumer products.
727152
New developments are brewing at the pharmaceutical.
268591
The Anglo-Dutch oil firm sets out to woo investors by explaining how it will boost its oil reserves at an analysts' briefing on Wednesday.